课题基金 / 基金详情

DEVELOPMENT OF DRUG WHICH REGULATES BONE RESORPTION ACTIVITY IN OSTEOCLASTS VIA CYTOSKELTON AND SIGNAL TRANSDUCTION SYSTEM

DEVELOPMENT OF DRUG WHICH REGULATES BONE RESORPTION ACTIVITY IN OSTEOCLASTS VIA CYTOSKELTON AND SIGNAL TRANSDUCTION SYSTEM
通过细胞骨架和信号传导系统调节破骨细胞骨吸收活性的药物的开发
批准号:
09470400
负责人:
OHYA Keiichi
金额:
$6.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

OHYA Keiichi的其他基金

相关文献

中文摘要
翻译
本研究旨在探讨质子(H+)在活性破骨细胞中的转运机制。我们用荧光pH指示剂测量了玻璃罩或骨片上分离的破骨细胞的细胞内pH (pHi)变化。酸负荷使破骨细胞产生H^+,细胞pHi迅速下降到静息水平以下。降低的pHi在无Na^+培养基中没有恢复,但在富Na^+培养基中恢复。在含有amiloride(一种有效的钠质子交换剂(NHE)抑制剂)的富Na+介质中,未观察到pHi的恢复。结果表明,玻璃上的破骨细胞具有通过NHE转运的H^+系统。相比之下,骨上的酸负载破骨细胞在添加阿米洛林和不添加Na+的情况下表现出pHi的恢复,这表明活性破骨细胞有除NHE以外的H+转运系统。从这些结果来看,与玻璃盖上的破骨细胞相比,破骨细胞至少有两种不同的H+转运机制,这表明破骨细胞附着在骨上激活了细胞内信号转导系统。另一方面,我们评估了双膦酸盐对低钙饮食大鼠骨细胞的影响。股骨和胫骨骨形态学分析显示,双膦酸盐抑制破骨细胞数量、破骨细胞核数量和成骨细胞数量的增加。双膦酸盐还能抑制矿化结节面积和抗酒石酸酸性磷酸酶阳性多核细胞数的增加。这些结果表明,双膦酸盐抑制低钙饮食激活的骨代谢的转换。
英文摘要
The aim of this study was to examine mechanisms of proton (H+ ) transport in active osteoclasts. We measured intracellular pH (pHi) changes in osteoclasts isolated on glasscoverslips or bone slices with a fluorescent pH indicator. H^+ was produced in osteoclasts by acid loading, and the pHi of the cells rapidly fell below the resting level. The decreased pHi did not recover in Na^+ free medium, but recovered in Na^+ rich medium. The pHi recovery was not observed on superfusion with Na+ rich medium containing amiloride, a potent sodium proton exchanger (NHE) inhibitor. The results reveal that osteoclasts on glass had H^+ transport system via NHE.In contrast, acid-loaded osteoclasts on bone showed their pHi recovery with amiloride and without Na+, presenting that active osteoclasts have H+ transport system other than NHE.From these results, osteoclasts have at least two different mechanisms of H+ transport compared to osteoclasts on glasscoverslips, suggesting that attachment to bone by osteoclasts activate intracellular signal transduction system.On the other hand, we evaluated the effects of bisphpsphonates on bone cells in rats fed with low calcium diet. Bone morphometrical analysis in femur and tibiae revealed that bisphpsphonates inhibited the increase of osteoclasts number, osteoclastic nucleus number, and osteoblasts number. Bisphpsphonates also inhibited the increment of mineralized nodule area and tartrate-resistant acid phosphatase positive-multi nuclear cells number. These results suggest that bisphpsphonates inhibit turnover in bone metabolism activated by low calcium diet.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kanno Z.,Shibata T.,Kasugai S.,Ohya K.,Soma K.: "Intracellular Calcium Response in Caltured Bone Cells under Mechanical Stress." J Jap Orthodont.Soc.発表予定.
Kanno Z.、Shibata T.、Kasugai S.、Ohya K.、Soma K.:“机械应力下培养骨细胞的细胞内钙反应”。Jap Orthodont.Soc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
瀬戸浩行: "低Ca食飼育ラットの海綿骨、皮質骨の骨量変化に関する研究" 歯科基礎医学会雑誌. 38.Suppl. 120- (1997)
Hiroyuki Seto:“低钙饮食大鼠松质骨和皮质骨骨量变化的研究”日本基础牙科医学会杂志 38.Suppl.120-(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SUZUKI K: "Effects of Surtacc Roughness of Titanium Implants on Bove Remodeling Activity of Femur in Rabbits" Bone. 21.6. 507-514 (1997)
SUZUKI K:“钛植入物 Surtacc 粗糙度对兔子股骨 Bove 重塑活动的影响”骨。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
青木和広: "低Ca状態におけるチルドロネートの骨吸収抑制効果について-低Ca食飼育ラットの実験的骨吸収でモデルによる検討-" 日本骨代謝学会雑誌. 15・2. 287- (1997)
Kazuhiro Aoki:“关于低 Ca 条件下替鲁膦酸对骨吸收的抑制作用 - 使用低 Ca 饮食的大鼠实验性骨吸收模型进行的检查”日本骨代谢学会杂志 15, 2. 287-(。 1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    New bone resrption inhibitor based on agonistic function for TNF type 2 receptor
    • 批准号:
      25670787
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of TNF-receptor Antagonists which have both Anti-inflammatory Action and Bone Formation Activity and Apply Them for the Treatment of Periodontal Diseases.
    • 批准号:
      24390413
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2012
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of new therapeutic drugs for inflammatory bone destruction by the CIAM compound, a new TNF receptor antagonist.
    • 批准号:
      19390471
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2007
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of New Hybrid-type Drugs Targeted to the Mechanism of Bone Remodeling
    • 批准号:
      16209053
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.12万
    • 财政年份:
      2004
    • 负责人:
      OHYA Keiichi
    • 依托单位: